The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRASG12C mutation. - Martin-Martin A; Chipón C; Guzman-Kunstmann C; Guzman-Kunstmann S; Buelvas N; Henríquez C; Vidal F; Villarroel-Espindola F; Hinz TK; Heasley LE; López-Muñoz RA (Biological research, 2026)